Despite finishing second to 2021’s record $151 billion worth of deals, 2022’s measure was still
more than $10 billion higher than its next closed year. Six of the top 10 largest private equity deals were in the life sciences and biopharma sectors, according to an April 10 Bain news release.
The report comes as some lawmakers look to crack down on private equity purchases of hospitals in their states.
“Change is coming as 2023 unfolds,” Nirad Jain, co-lead of healthcare private equity at Bain & Co., said in the release “Investors who have previously weathered down cycles have specialized playbooks for these times, to which they will adapt their usual approach. This includes playing to long-term trends and getting creative to close deals amid capital and inflationary restraints.”
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.